limonin has been researched along with oxidopamine in 1 studies
| Studies (limonin) | Trials (limonin) | Recent Studies (post-2010) (limonin) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 159 | 0 | 106 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | limonin (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, M; Fu, S; Gao, X; He, D; He, Y; Li, J; Li, Z; Liu, D; Liu, Y; Wang, H; Ye, B | 1 |
1 other study(ies) available for limonin and oxidopamine
| Article | Year |
|---|---|
Oral administration of Limonin (LM) exerts neuroprotective effects by inhibiting neuron autophagy and microglial activation in 6-OHDA-injected rats.
Topics: Administration, Oral; Aged; Animals; Autophagy; Humans; Inflammation; Limonins; Microglia; Middle Aged; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats | 2023 |